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The endophilin family of proteins function in clathrin-
mediated endocytosis. Here, we have identified and
cloned the rat germinal center kinase-like kinase
(rGLK), a member of the GCK (germinal center kinase)
family of c-Jun N-terminal kinase (JNK) activating en-
zymes, as a novel endophilin I-binding partner. The
interaction occurs both in vitro and in cells and is me-
diated by the Src homology 3 domain of endophilin I and
a region of rGLK containing the endophilin consensus-
binding sequence PPRPPPPR. Overlay analysis of rat
brain extracts demonstrates that endophilin I is a major
Src homology 3 domain-binding partner for rGLK. Over-
expression of full-length endophilin I activates rGLK-
mediated JNK activation, whereas N- and C-terminal
fragments of endophilin I block JNK activation. Thus,
endophilin I appears to have a novel function in JNK
activation.
Src homology 3 (SH3)1 domains are protein modules that
bind to specific proline-rich sequences (1). SH3 domains were
identified originally in proteins of signal transduction cascades,
and they have also been found to mediate protein-protein in-
teractions important for regulation of endocytosis (2). Recent
studies have revealed biochemical and functional interactions
between protein components of the regulatory machinery for
endocytosis and those of signal transduction pathways (3). For
example, both intersectin and amphiphysin II are SH3 domain-
containing proteins that function in endocytosis and also bind
to the Ras-activating enzyme mammalian son-of-sevenless
(mSos) (4, 5). Overexpression of the SH3 domains of intersectin
blocks epidermal growth factor-mediated activation of Ras (5)
and the extracellular signal-regulated kinase (Erk) MAP ki-
nases (6, 7) demonstrating the functional significance of the
intersectin-mSos interaction.
Another SH3 domain-containing protein that functions in
clathrin-mediated endocytosis is endophilin (8–10). Three iso-
forms of endophilin have been identified: endophilin I, which is
brain-specific; endophilin II, which is ubiquitously distributed;
and endophilin III, which is expressed in brain and testis
(8–13). Overexpression of the C-terminal SH3 domain of en-
dophilin I-permeabilized mammalian cells (14) or in lamprey
synapses (15, 16) blocks clathrin-coated vesicle formation. At its
N terminus, endophilin I encodes a lysophosphatidic acid acyl-
transferase activity that has been suggested to regulate mem-
brane curvature and hence clathrin-coated vesicle formation (17).
Through its SH3 domain, endophilin I has been reported to
interact with a variety of partners including the endocytic
proteins synaptojanin 1, dynamin 1, and the amphiphysins
(8–10, 18), as well as the b1-adrenergic receptor (19) and
specific metalloprotease disintegrins (20). To better under-
stand these and other interactions mediated by endophilin I,
we screened a rat brain expression library with the endophilin
I SH3 domain. We identified synaptojanin 1 and dynamin 1,
and surprisingly, we also identified and cloned a rat homologue
of the human germinal center kinase-like kinase (hGLK).
hGLK was identified originally based on its homology to mem-
bers of the germinal center kinase (GCK) family of protein
kinases (21) and is a group I GCK (22). Group I GCKs are
mitogen-activated protein kinase kinase kinase kinases
(MAP4Ks) that function upstream of c-Jun N-terminal kinase
(JNK) in a variety of cell types (22). Group I GCKs are com-
posed of an N-terminal kinase domain and a C-terminal regu-
latory domain with multiple SH3 domain consensus-binding
sites (22). The mechanisms by which events at the cell surface
are linked to activation of GLK and other GCKs remain poorly
understood. Moreover, the identity of SH3 domain-containing
binding partners for GLK and the potential role for such pro-
teins in regulation of GLK function have not been addressed.
The identification of rat GLK (rGLK) as an endophilin I-
binding partner suggests a role for endophilin in the regulation
of GLK function. To explore this role, we first confirmed the
rGLK-endophilin I interaction in multiple systems in vitro and
by co-immunoprecipitation analysis. Overlay assays of rat
brain extracts revealed endophilin I as a major SH3 domain-
binding partner for rGLK. Moreover, endophilin I was found to
regulate GLK-mediated JNK activation. These data implicate
endophilin I in the activation of JNK and provide evidence of a
link between the endocytic machinery and the JNK signaling
pathway.
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EXPERIMENTAL PROCEDURES
cDNA Expression Library Screen—An oligo(dT)-primed l-ZAP II rat
brain cDNA expression library, size-selected for clones greater than 4
kilobase pairs (Ref. 23; gift from Dr. Terry Snutch, University of British
Columbia), was plated at 20,000 plaque-forming units/150-mm plate.
Protein expression was induced using isopropyl-b-D-thiogalactopyrano-
side-soaked nitrocellulose filters that were then screened by overlay
assays (24) using a GST fusion protein encoding the SH3 domain of
endophilin I (9). Positive plaques were purified by two additional
rounds of screening, and the cDNAs were isolated and identified by
DNA sequence analysis. The longest clone encoding rGLK was com-
pletely sequenced on both strands.
Antibodies—Polyclonal antibodies against amphiphysin I/II (25) and
endophilin I (1903) (9) were described previously. Monoclonal anti-
FLAG M2 and anti-phospho-JNK (Thr183-Tyr185) antibodies were pur-
chased from Sigma and New England Biolabs, respectively.
Generation of GST Fusion Protein Constructs—GST fusion proteins
encoding full-length endophilin I or its isolated SH3 domain were de-
scribed previously (9). GST fusion protein constructs of rGLK encoding
various regions of the regulatory domain were generated using an
rGLK cDNA clone as a template in PCR reactions. The reactions were
performed with the forward primer 59-GCGGGATCCCCTCTGACGAG-
GTCTTTG (nucleotides 826–843) and the following reverse primers:
GST-GLK-(276–541), 59-GCGCCCGGGTCAGGCACAGTGGATTTTC-
AAG (nucleotides 1605–1623); GST-GLK-(276–498), 59-GCGCCCGGG-
TCAGTTCGTGCCTCTCTGCTC (nucleotides 1477–1494); GST-GLK-
(276–445), 59-GCGCCCGGGTCACCCTGATGAGGGACATC (nucleot-
ides 1319–1335); GST-GLK-(276–406), 59-GCGCCCGGGTCACAAGG-
TTGAATGTTTAGAGTC (nucleotides 1198–1218). The resulting PCR
products were subcloned into the corresponding BamHI and SmaI sites
of pGEX-2T (Amersham Pharmacia Biotech), and the resulting GST
fusion proteins were expressed and purified using standard procedures.
Generation of Constructs for Mammalian Expression—Mammalian
expression constructs for full-length endophilin I and endophilin I lack-
ing the SH3 domain (delta SH3) were generated by digesting the cor-
responding GST fusion protein constructs (9) with BamHI and EcoRI
with the resulting inserts subcloned into the corresponding sites of
pcDNA3 (Invitrogen). An N-terminal green fluorescent protein (GFP)-
tagged mammalian expression construct for the SH3 domain of en-
dophilin I was generated by PCR using the full-length cDNA (11) as a
template, with the forward primer 59-GCGAGATCTCTCAGCCAA-
GAAGGGAATATC and the reverse primer 59-GCGGAATTCTCAAT-
GGGGCAGAGCAACCAG. The resulting PCR product was digested
with BglII and EcoRI and subcloned into the corresponding sites of
pEGFP-C2 (CLONTECH). To generate a construct encoding rGLK with
an N-terminal FLAG tag, PCR was performed with the forward primer
59-GCGAAGCTTGCCACCATGGACTACAAAGACGATGACGACAAA-
CCGCAGGAGGACTTCG (nucleotides 34–49), which includes an initi-
ation ATG codon within the context of a Kozak consensus sequence (26)
and a FLAG epitope (DYKDDDDK), and the reverse primer 59-GCGG-
GATCCTCACTGTGTGACAAAGGGATG (nucleotides 808–825). The
resulting PCR product was digested with HindIII and KpnI and sub-
cloned into the same sites at the 59-end of the longest rGLK library
clone in pBluescript. The resulting FLAG-tagged rGLK construct was
then digested with HindIII and BamHI sites, and the insert was sub-
cloned into the same sites in pcDNA3. FLAG-tagged GCK (27) and JNK
constructs were generous gifts from Dr. John Kyriakis (Massachusetts
General Hospital) and Dr. Nathalie Lamarche-Vane (McGill University),
respectively.
Binding Assays—For cultured cells, 10-cm2 dishes of transfected
HEK-293T cells were washed in phosphate-buffered saline (20 mM
NaH2PO4, 0.9% NaCl, pH 7.4) and scraped into buffer A (20
mM HEPES-OH, pH 7.4, 150 mM NaCl, 0.83 mM benzamidine, 0.23 mM
phenylmethylsulfonyl fluoride, 0.5 mg/ml aprotinin, and 0.5 mg/ml leu-
peptin). The cells were sonicated and passed through a 25-5⁄8-gauge
needle, Triton X-100 was added to a final concentration of 1%, and
following incubation for 20 min at 4 °C the samples were centrifuged at
75,000 rpm in a Beckman TLA 100.1 rotor. Aliquots of the soluble
supernatant were diluted to 2 mg of protein/ml in buffer A with 1%
Triton X-100, and 1-ml samples were incubated overnight at 4 °C with
;25 mg of GST fusion proteins prebound to glutathione-Sepharose. The
bead samples were subsequently washed in buffer A with 1% Triton
X-100, eluted with SDS-PAGE sample buffer, and prepared for Western
blot analysis. For brain extracts, adult rat brains were homogenized in
buffer B (20 mM HEPES-OH, pH 7.4, 0.83 mM benzamidine, 0.23 mM
phenylmethylsulfonyl fluoride, 0.5 mg/ml aprotinin, and 0.5 mg/ml leu-
peptin) and centrifuged at 750 3 gmax for 15 min. The supernatant was
centrifuged at 45,000 rpm in a Sorval T-865 rotor for 1 h, and the
soluble supernatant was diluted to 2 mg/ml in buffer B. Triton X-100
was added to a final concentration of 1%, and 1-ml aliquots were
incubated o/n at 4 °C with ;25 mg of GST fusion proteins prebound to
glutathione-Sepharose. The beads were subsequently washed three
times in 1 ml of buffer B with 1% Triton X-100, eluted with SDS-PAGE
sample buffer, and prepared for Western blot analysis. Overlay assays
were performed as described (24).
Immunoprecipitation Assays—Extracts from HEK-293T cells trans-
fected with various cDNA constructs were prepared as described above
and were precleared with either protein A-Sepharose or protein G-
agarose beads. The precleared supernatants were then incubated with
pre-immune serum or anti-endophilin I antibody (1903) coupled to
protein A-Sepharose beads or with anti-FLAG antibody coupled to
protein G-agarose beads. After 5 h at 4 °C, the beads were washed
extensively in buffer A with 1% Triton X-100 and prepared for Western
blotting analysis.
JNK Assays—HEK-293T cells were co-transfected with FLAG-
tagged JNK and a variety of constructs as indicated in the figure
legends. 48 h post-transfection, the medium was removed and the cells
were scraped and boiled in sample buffer. The samples were separated
on SDS-PAGE and used for Western blot analysis.
RESULTS
Identification and Cloning of Rat Germinal Center Kinase-
like Kinase as an Endophilin I-binding Protein—To better un-
derstand the complete range of endophilin I functions, we
sought to identify its full complement of SH3 domain-binding
partners. We thus screened a rat brain expression library with
a GST fusion protein encoding the SH3 domain of endophilin I.
From a total of approximately 600,000 clones screened, 18
encoded potential endophilin I-binding proteins (data not
shown). As expected, the majority of the clones (eight) encoded
for synaptojanin 1. Only one clone was found to correspond to
dynamin 1. Interestingly, three independent, non-amplified
isolates were found to encode for a rat homologue of the human
serine/threonine protein kinase, hGLK (21). It is particularly
striking that more independent clones of rGLK were isolated
than for dynamin I, which is an abundant brain protein and is
a well established endophilin I-binding partner (9, 10). This
result is consistent with a high affinity interaction between
endophilin I and rGLK.
The longest rGLK clone isolated was sequenced on both
strands to generate a coding sequence that aligned to hGLK,
starting at amino acid 3 of its published sequence (21), and
appeared to be complete at the C-terminal end. To obtain the
extreme 59-end, we searched the data base of expressed se-
quence tags (dbEST) with a sequence from near the 59-end of
our isolated clones. Four overlapping rat ESTs were identified
leading to a complete rGLK coding sequence containing 11
additional amino acids (Fig. 1A). These amino acids, which
extend the rGLK sequence 8 amino acids beyond the predicted
start of hGLK, were homologous to other members of the GCK
family (data not shown). The differences in the extreme N-
terminal end of hGLK and rGLK may represent a species
difference. However, multiple human EST clones were identi-
fied, which when aligned with the 59-end of hGLK could define
an N-terminal sequence identical to that for rGLK (data not
shown).
Protein alignments revealed that the N-terminal kinase do-
main of rGLK is 99 and 72% identical to hGLK and hGCK,
respectively (Fig. 1B). The C-terminal regulatory domain of
rGLK, which includes a proline-rich region, is 95% identical
with hGLK and 44% identical with hGCK (Fig. 1B).
rGLK Binds the SH3 Domain of Endophilin I via an En-
dophilin Consensus-binding Sequence—To confirm the en-
dophilin I-rGLK interaction, we transfected HEK-293T cells
with a construct encoding rGLK containing an N-terminal
FLAG tag (FLAG-rGLK). The expressed protein bound strongly
to a GST-endophilin I SH3 domain fusion protein (GST-SH3)
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but not to GST alone (Fig. 2A, upper panels). To further dem-
onstrate the interaction specificity, we assessed the binding of
FLAG-tagged GCK (27) (generously provided by Dr. John Kyri-
akis). No binding of FLAG-GCK to the SH3 domain of endophi-
lin I was detected (Fig. 2A, upper panels). We next performed
the converse pull-down experiments. Full-length endophilin I
expressed in HEK-293T cells bound specifically to a GST fusion
protein encoding the proline-rich core of rGLK (GST-GLK-
FIG. 1. Sequence and structure of rGLK. A, the nucleic acid and complete coding sequence of rGLK is shown. The N-terminal sequence,
determined from four overlapping rat EST clones, is underlined. The boxed amino acids represent consensus SH3 domain-binding sites. The nucleic
acid position numbers are indicated on the right. B, rGLK is shown aligned to hGLK and hGCK. The N-terminal kinase domain and C-terminal
regulatory domain (including the proline-rich core) are indicated. The amino acid position numbers of rGLK that define each domain are indicated
along the top of the protein. The percent identity between the various domains is indicated.
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(276–541)) (Fig. 2A, lower panels). In contrast, an endophilin I
construct lacking the SH3 domain (endophilin I delta SH3) did
not bind to the same rGLK fusion protein (Fig. 2A, lower
panels). The endophilin I-rGLK interaction was also demon-
strated from brain tissue. GST-GLK-(276–541) strongly affin-
ity-selected endophilin I from brain extracts, whereas am-
phiphysin I and II, two major SH3 domain-containing proteins
in brain (25), bound only weakly to the fusion protein (Fig. 2B).
The binding of amphiphysin I and II, although weak, is specific
as neither protein nor endophilin I bound to GST alone (Fig. 2B).
The proline-rich core of rGLK contains multiple consensus
SH3 domain-binding sites. To begin to identify the proline-rich
motif(s) responsible for endophilin I binding, we generated GST
fusion protein constructs deleting increasing amounts of the C
terminus of the rGLK regulatory domain (Fig. 3A). Whereas
constructs consisting of amino acids 276–541 (GST-GLK-(276–
541)) and 276–498 of rGLK (GST-GLK-(276–498)) bound
strongly to endophilin I from brain extracts, a construct encod-
ing amino acids 276–445 (GST-GLK-(276–445)) showed weak
binding, and a construct encoding amino acids 276–406 (GST-
GLK-(276–406)) failed to bind (Fig. 3B). The major endophilin
I-binding site is thus located between amino acids 445 and 498
of rGLK with a second, weaker site between amino acids 405
and 446. Within the region of rGLK from amino acids 445–498
is the sequence PPRPPPPR (Fig. 3C), which closely conforms to
the previously described SH3 domain consenus-binding se-
quence for the endophilins (28). This sequence is thus the likely
endophilin I-binding site in rGLK.
Endophilin I Is a Major rGLK-binding Protein—Members of
the GCK family have been reported to interact with a number
of different SH3 domain-containing proteins (22). To determine
whether rGLK has multiple SH3 domain-binding partners, we
performed overlay assays of brain extracts with the GST-rGLK
fusion protein constructs described above. Remarkably, GST-
GLK-(276–541) reacted with a single 40-kDa band that per-
fectly co-migrated with endophilin I as determined by Western
blot with an endophilin I antibody (Fig. 4A). GST-GLK-(276–
498), which like GST-GLK-(276–541) interacts with endophilin
I in pull-down assays, also bound to the 40-kDa band. In
contrast, GST-GLK-(276–445) and GST-GLK-(276–406),
which bind to endophilin I in pull-down assays, either very
weakly or not at all, do not recognize the 40-kDa band (Fig. 4A).
A similar specificity was seen with overlay assays of recombi-
nant endophilin I (data not shown). These data thus suggest
that endophilin I is the major rGLK-binding protein in the
brain. Previously, we performed overlays with the SH3 domain
of endophilin I that revealed dynamin I and synaptojanin 1 as
the major endophilin I-binding partners in the brain (9). How-
ever, dynamin I and rGLK both migrate on SDS-PAGE at ;100
kDa, so it is possible that the 100-kDa band detected in these
experiments represented a mixture of dynamin I and rGLK. To
further explore this issue, we performed overlays with GST or
GST-endophilin I on brain extracts run on gels side-by-side
with immunoprecipitated FLAG-rGLK and FLAG-GCK. En-
dophilin I reacted strongly with bands in the brain extract at
100 and 145 kDa, identified previously as dynamin and synap-
tojanin, respectively (9). Endophilin I also reacted with FLAG-
rGLK, which migrated almost perfectly with dynamin, whereas
no reactivity was seen with FLAG-GCK (Fig. 4B). A Western
blot with an anti-FLAG antibody confirmed the presence of
FLAG-rGLK and FLAG-GCK in the immunoprecipitated sam-
ples (Fig. 4B). Together, these results suggest a strong and
highly specific interaction of endophilin I with rGLK.
Co-immunoprecipitation of rGLK and Endophilin I—To
demonstrate the interaction in cells, lysates from HEK-293T
cells co-transfected with FLAG-rGLK and full-length endophi-
lin I were subjected to immunoprecipitation analysis with an
anti-endophilin I antibody (1903) and an anti-FLAG antibody.
Immunoprecipitation of either endophilin I or FLAG-rGLK led
to the co-immunoprecipitation of the respective binding part-
ner (Fig. 5A). In control experiments, no co-immunoprecipita-
tion was seen when cells were co-transfected with FLAG-rGLK
and an endophilin I construct lacking the SH3 domain (en-
dophilin I delta SH3) (Fig. 5A).
Endophilin I Regulates GLK-mediated JNK Activation—It
was previously reported that overexpression of hGLK leads to
JNK activation in transfected HEK-293 cells (21). We thus
used this system to determine whether endophilin I functions
in GLK-mediated JNK activation. Specifically, we monitored
JNK activation using an anti-phospho-JNK antibody following
transfection of GLK and different endophilin I constructs. Con-
sistent with Diener et al. (21), we found that overexpression of
rGLK is sufficient to activate JNK (Fig. 5B). Interestingly,
overexpression of full-length, untagged endophilin I along with
rGLK causes an increase in JNK activation versus expression
of GLK alone (Fig. 5B). Quantitative analysis of eight inde-
FIG. 2. Characterization of endophilin I-rGLK interactions. A,
Triton X-100 soluble extracts were prepared from HEK-293T cells
transfected with FLAG-rGLK or FLAG-GCK (upper panels) or with
full-length endophilin I or endophilin I lacking the SH3 domain (en-
dophilin I delta SH3, lower panels). The extracts were incubated with
GST or with GST fusion proteins of either the SH3 domain of endophilin
I (GST-SH3) or a portion of the proline-rich regulatory domain of rGLK
(GST-GLK276–541) prebound to glutathione-Sepharose. Proteins specif-
ically bound to the beads were processed for Western blots along with
an aliquot of the soluble extract (starting material (sm)) and an equal
amount of the unbound material (void). The panels show immunoblots
with anti-FLAG (upper panels) or anti-endophilin I (lower panels). B,
GST or GST-GLK-(276–541) conjugated to glutathione-Sepharose
beads were incubated with soluble extracts from rat brain. Proteins
specifically bound to the beads along with equal aliquots of the soluble
brain extract (starting material (sm)) and unbound material (void) were
processed for Western blots with an antibody recognizing amphiphysin
I and II (upper panel) or endophilin I (lower panel).
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pendent experiments revealed a statistically significant (p ,
0.05; two-tailed t test) 2.01-fold stimulation. Further, overex-
pression of a GFP-tagged form of the SH3 domain of endophilin
I or of the untagged N terminus of endophilin I lacking the SH3
domain (delta SH3) completely blocked GLK-mediated JNK
activation (Fig. 5B). Given that the SH3 domain of endophilin
I was expressed with a GFP tag, we sought to further demon-
strate the specificity of this construct to block rGLK-mediated
JNK activation. Thus, JNK activation was measured following
overexpression of rGLK with the GFP-SH3 domain construct or
with GFP alone. Whereas the GFP-endophilin I SH3 domain
blocked rGLK-mediated JNK activation, GFP alone had no
effect (Fig. 5C). Together, these data demonstrate that en-
dophilin I can function to regulate GLK-mediated JNK
activation.
DISCUSSION
Previous studies have established a role for endophilin I in
clathrin-mediated endocytosis (14–16). Our data, demonstrat-
ing a functional role for endophilin I in rGLK-mediated JNK
activation, suggest an additional and perhaps complementary
role for endophilin I in signaling via the JNK pathway. Several
recent studies have demonstrated that proteins that function
in endocytosis can also function in the regulation of cell signal-
ing. For example, both amphiphysin II and intersectin demon-
strate SH3 domain-dependent interactions with the Ras-acti-
vating enzyme mSos (4, 5), and overexpression of the SH3
domains of intersectin blocks epidermal growth factor-medi-
ated activation of Erk1/2 (6, 7). Moreover, b-arrestin 1, a clath-
rin-binding protein that functions to target activated G protein-
coupled receptors to clathrin-coated pits, also functions as a
FIG. 3. Identification of an endophilin-binding site in rGLK. A, domain model of GST fusion protein constructs of the proline-rich core of
rGLK. B, soluble extracts prepared from rat brain were incubated with the rGLK fusion proteins conjugated to glutathione-Sepharose. Proteins
specifically bound to the beads along with aliquots of the soluble brain extract (starting material (sm)) and equal amounts of the unbound material
(void) were processed for Western blot with an antibody against endophilin I. C, amino acid sequence alignment of a portion of the regulatory
domains including the proline-rich cores, of hGLK, rGLK, and hGCK. Homologous residues are lightly shaded, SH3 domain-consensus binding
sites are more darkly shaded, and the likely endophilin I-binding site is the most darkly shaded.
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scaffolding protein for Erk1/2 and its upstream activating ki-
nase, Raf-1 (29). In fact, agonists of the Gaq-coupled protein-
ase-activated receptor 2 stimulate the formation of a complex
containing receptor, b-arrestin 1, Raf-1, and activated Erk1/2
on endocytic vesicles (29). Thus, proteins that function in en-
docytosis can also regulate the Erk MAP kinases.
Recent studies have also suggested a function for endocytic
proteins in regulation of the JNK MAP kinases. For example,
following stimulation with ligand, the angiotensin II type 1A
receptor is targeted to the endocytic pathway through interac-
tions with b-arrestin 2 (30). Interestingly, b-arrestin 2 also
binds to JNK3, and activation of the angiotensin II type 1A
receptor leads to the formation of a receptor-b-arrestin 2-JNK3
complex on endocytic vesicles (30). The formation of this com-
plex is necessary for ligand-induced JNK3 activation (30). Fur-
ther, Fish et al. (31) determined that overexpression of wild-
type dynamin II, but not a GTPase defective mutant of the
protein, activates the transcription factor p53 and induces ap-
optosis. These data suggest a possible role for dynamin in JNK
activation as JNKs are potent effectors of apoptosis (32). More-
over, dynamin 1 binds directly to mixed lineage kinase 2, an
upstream activator of JNK (33). Thus, distinct protein compo-
nents of the endocytic regulatory machinery appear to function
in the activation of MAP kinase signaling pathways including
those involving JNKs. The data presented here, demonstrating
a functional interaction between endophilin I and rGLK, fur-
ther support the importance of such a link.
A clue to the mechanism by which endophilin I may regulate
hGLK-mediated JNK activation has come from the study of
Diener et al. (21) who determined that deletion of the regula-
tory domain of hGLK, including the SH3 domain-binding sites,
resulted in a kinase that had full catalytic activity but that was
significantly impaired in its ability to activate JNK. These data
are consistent with a model in which the regulatory domain
FIG. 4. rGLK overlay assays. A, overlay assays using the GST-
rGLK fusion protein constructs shown in Fig. 3A were performed on
strips of rat brain post-nuclear supernatants on nitrocellulose. Coomas-
sie Blue staining reveals the complement of proteins, and an endophilin
I antibody (1903) was used to indicate the migratory position of rat brain
endophilin I. B, overlays using GST alone or GST-endophilin I were per-
formed on an aliquot of rat brain extract as well as on FLAG-rGLK and
FLAG-GCK immunoprecipitated from transfected cells. An anti-FLAG
Western blot reveals the presence of rGLK and GCK on the blots.
FIG. 5. Endophilin I regulates rGLK-mediated JNK activation.
A, Triton X-100-soluble extracts of HEK-293T cells, co-transfected with
FLAG-rGLK and either full-length endophilin I or endophilin I lacking
the SH3 domain (endophilin I delta SH3), were used for immunopre-
cipitation analysis using anti-FLAG, anti-endophilin I (1903), or pre-
immune 1903 (pre-immune). Proteins specifically bound to the beads
were processed for Western blots with anti-FLAG (upper panel) or
anti-endophilin I (lower panel) antibodies. B, HEK-293T cells were
transfected with control plasmid, FLAG-JNK, FLAG-rGLK, full-length
endophilin I, endophilin I lacking the SH3 domain, or GFP-SH3 domain
of endophilin I either alone or in various combinations as indicated. 48 h
following transfections, the cells were scrapped and processed for West-
ern blots with anti-FLAG, anti-endophilin, or anti-PO4-JNK antibodies
as indicated. C, HEK-293T cells were transfected with FLAG-JNK,
FLAG-rGLK, GFP, or GFP-SH3 domain of endophilin I as indicated.
48 h after transfections, the cells were scrapped and processed for
Western blots with anti-FLAG, anti-endophilin, or anti-PO4-JNK anti-
bodies as indicated. For all of the blots, the migratory positions of the
proteins are indicated on the left.
Endophilin Regulates GLK Function28918
targets rGLK for the interactions necessary for JNK activation.
Thus, endophilin I may function as an adaptor protein to target
rGLK to an upstream activator or to a downstream effector
functioning in JNK activation. In fact, other GCKs appear to
undergo specific targeting events. For example, the group 1
GCK family member HPK1 is activated following its recruit-
ment to the epidermal growth factor receptor via interactions
with the SH3 domain-containing adaptor protein Grb2 (34).
GCK itself is targeted to the Golgi complex via its interactions
with the membrane-trafficking protein Rab8 (35). Regardless
of its precise functional role, the data presented here unveil a
novel interaction between endophilin and rGLK and strongly
suggest a role for endophilin I in regulation of JNK activity.
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